T1	OrganismPart 0 5	Brain
T2	Disease 107 155	Alzheimer's disease with cerebrovascular disease
T5	Modification 212 216	DPMs
T4	Modification 176 210	degenerative protein modifications
T6	OrganismPart 170 175	Brain
T7	Disease 272 280	dementia
T8	Disease 304 352	Alzheimer's disease with cerebrovascular disease
T9	Disease 354 362	AD + CVD
*	Equiv T8 T9
T10	Disease 394 402	dementia
T11	Age 410 415	elder
T12	OrganismPart 463 468	brain
T13	Modification 469 472	DPM
T14	Disease 482 490	dementia
T3	Organism 687 692	human
T16	Modification 723 728	uDPMs
T19	Modification 892 897	uDPMs
T20	Disease 923 931	dementia
T21	Separation 1012 1094	ultracentrifugation-electrostatic repulsion hydrophilic interaction chromatography
T22	Separation 1096 1104	UC-ERLIC
*	Equiv T21 T22
T23	TechnologyType 1114 1131	mass spectrometry
T24	Modification 1190 1195	uDPMs
T25	OrganismPart 1238 1243	brain
T26	Disease 1281 1289	AD + CVD
T27	Disease 1396 1404	AD + CVD
T28	OrganismPart 1405 1411	brains
T29	Modification 1357 1362	uDPMs
T30	Disease 1496 1504	AD + CVD
T31	Disease 1608 1616	AD + CVD
T32	OrganismPart 1617 1623	brains
T33	Disease 1633 1641	dementia
T34	Compound 1651 1661	citrulline
T35	Disease 1948 1956	AD + CVD
T36	Disease 1855 1863	dementia
T37	Compound 1873 1886	homocitrullin
T39	Disease 2283 2291	AD + CVD
T40	Modification 2233 2238	uDPMs
T41	Disease 2552 2560	Dementia
T42	Disease 2706 2725	Alzheimer's disease
T43	Disease 2727 2729	AD
*	Equiv T42 T43
T44	Disease 2828 2851	Cerebrovascular disease
T45	Disease 2853 2856	CVD
*	Equiv T44 T45
T46	Disease 2923 2925	AD
T47	Disease 2929 2937	AD + CVD
T48	Disease 2955 2963	dementia
T49	Modification 3163 3197	degenerative protein modifications
T50	Modification 3199 3203	DPMs
T51	Modification 3434 3438	DPMs
T55	Modification 3770 3793	Carbamylation of lysine
T56	Compound 3851 3883	urea intermediate isocyanic acid
T57	Modification 17294 17326	Carbamidomethylation of cysteine
T58	CleavageAgent 17218 17225	Trypsin
T59	Instrument 15295 15309	Orbitrap Elite
T60	Disease 18152 18160	AD + CVD
T61	Modification 18318 18331	citrullinated
T62	Modification 18342 18354	carbamylated
T63	Separation 15499 15524	Acclaim PepMap RSL column
T64	Temperature 15611 15613	35
T65	Time 15690 15705	60-min gradient
T66	MS2MassAnalyzer 16172 16230	Michrom's Thermo Captive Spray nanoelectrospray ion source
T67	Disease 18483 18491	AD + CVD
T68	NumberOfSamples 18556 18559	two
T69	Disease 8288 8296	AD + CVD
T70	Disease 8301 8308	healthy
T71	Disease 8321 8328	control
T72	OrganismPart 8346 8351	human
T73	OrganismPart 8352 8357	brain
T74	OrganismPart 8367 8387	middle temporal lobe
T75	OrganismPart 8389 8400	BA21 region
T76	SupplementaryFile 8728 8755	Additional file 1: Table S1
T77	NumberOfBiologicalReplicates 8757 8762	Three
T78	OrganismPart 8896 8901	Brain
T79	OrganismPart 9016 9020	BA21
T80	OrganismPart 9210 9215	brain
T81	Separation 10423 10505	ultracentrifugation-electrostatic repulsion hydrophilic interaction chromatography
T82	Separation 10507 10515	UC-ERLIC
*	Equiv T81 T82
T15	FactorValue 17734 17737	108
T17	Disease 19495 19503	AD + CVD
T18	Depletion 19795 19814	sodium deoxycholate
T38	Depletion 19816 19819	SDC
*	Equiv T18 T38
T52	SupplementaryFile 20391 20454	Additional file 3 : Figure S1a and Additional file 4: Dataset 2
T53	Modification 20548 20552	uDPM
T83	Disease 20666 20674	AD + CVD
T84	Separation 21585 21593	UC-ERLIC
T85	SampleTreatment 19795 19814	sodium deoxycholate
T86	SampleTreatment 19816 19819	SDC
T87	Disease 21651 21659	AD + CVD
T88	SupplementaryFile 21661 21689	Additional file 5: Dataset 3
T89	Disease 21936 21944	AD + CVD
